Englander Institute for Precision Medicine

Artificial intelligence in cancer research, diagnosis and therapy.

TitleArtificial intelligence in cancer research, diagnosis and therapy.
Publication TypeJournal Article
Year of Publication2021
AuthorsElemento O, Leslie C, Lundin J, Tourassi G
JournalNat Rev Cancer
Volume21
Issue12
Pagination747-752
Date Published2021 Dec
ISSN1474-1768
KeywordsArtificial Intelligence, Biomedical Research, Drug Discovery, Humans, Machine Learning, Medical Oncology, Neoplasms
Abstract

Artificial intelligence and machine learning techniques are breaking into biomedical research and health care, which importantly includes cancer research and oncology, where the potential applications are vast. These include detection and diagnosis of cancer, subtype classification, optimization of cancer treatment and identification of new therapeutic targets in drug discovery. While big data used to train machine learning models may already exist, leveraging this opportunity to realize the full promise of artificial intelligence in both the cancer research space and the clinical space will first require significant obstacles to be surmounted. In this Viewpoint article, we asked four experts for their opinions on how we can begin to implement artificial intelligence while ensuring standards are maintained so as transform cancer diagnosis and the prognosis and treatment of patients with cancer and to drive biological discovery.

DOI10.1038/s41568-021-00399-1
Alternate JournalNat Rev Cancer
PubMed ID34535775

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021